Shots: The P-III Archway study involves assessing of PDS with ranibizumab, refilled @6mos. at fixed intervals, vs ranibizumab (0.5mg, monthly IVT) in 418 patients with nAMD, prior treated with VEGF […]readmore
Tags : Archway Study
Shots: The P-III Archway study involves assessing the efficacy and safety of Port Delivery System with ranibizumab (PDS), refilled q6w at fixed intervals vs monthly IVT of ranibizumab (0.5mg) in […]readmore